Trial Profile
Efficacy of fingolimod treatment in patients with relapsing-remitting multiple sclerosis who had undergone prior treatment with natalizumab
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 10 Dec 2015 New trial record